Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep;11(9):3676-3680.
doi: 10.21037/jtd.2019.09.26.

Probability of benefit with the use of neuromuscular blockade in patients with acute respiratory distress syndrome

Affiliations
Editorial

Probability of benefit with the use of neuromuscular blockade in patients with acute respiratory distress syndrome

Guilherme Martins de Souza et al. J Thorac Dis. 2019 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Results of the Bayesian hierarchical meta-analysis. (A) Posterior probability distribution of the pooled results of the meta-analysis (full posterior density from the Markov chain Monte Carlo approach, the red area is where risk ratio >1 and NMBA increase mortality); (B) resulting estimated posterior probability that the risk ratio for mortality exceeds that threshold value according to different down-weightings of previous studies (if these weights are equal to 1, a meta-analysis of all studies are carried out, on the other hand, with the decrease in these weights, the importance of previous studies decrease and when these weights are equal to 0, then we learn nothing about the risk ratio for NMBA from previous studies, and with a minimally informative prior the results represent the analysis of the ROSE trial alone). ROSE trial, Reevaluation of Systemic Early Neuromuscular Blockade trial; NMBA, neuromuscular blocking agents.

Comment on

  • Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, Hite RD, Hou PC, Hough CL, Iwashyna TJ, Khan A, Liu KD, Talmor D, Thompson BT, Ulysse CA, Yealy DM, Angus DC. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, et al. N Engl J Med. 2019 May 23;380(21):1997-2008. doi: 10.1056/NEJMoa1901686. Epub 2019 May 19. N Engl J Med. 2019. PMID: 31112383 Free PMC article. Clinical Trial.

References

    1. Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. JAMA 2018;319:698-710. 10.1001/jama.2017.21907 - DOI - PubMed
    1. Bellani G, Laffey JG, Pham T, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 2016;315:788-800. 10.1001/jama.2016.0291 - DOI - PubMed
    1. Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, et al. Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study. Am J Respir Crit Care Med 2012;185:517-24. 10.1164/rccm.201103-0503OC - DOI - PMC - PubMed
    1. Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2017;195:1253-63. 10.1164/rccm.201703-0548ST - DOI - PubMed
    1. Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004;32:113-9. 10.1097/01.CCM.0000104114.72614.BC - DOI - PubMed